Induction of necrotic tumor cell death by TRAIL/Apo-2L (original) (raw)
- Wyllie AH, Kerr JF, Currie AR. Cell death: The significance for apotosis. Int Rev Cytol 1980; 68: 251–306.
Google Scholar - Cohen JJ. Apoptosis. Immunol Today 1993; 14: 126–130.
Google Scholar - Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 93: 2239–2244.
Google Scholar - Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.
Google Scholar - McConkey DJ, Nicotera P, Orrenius S. Signalling and chromatin fragmentation in thymocyte apoptosis. Immunol Rev 1994; 142: 341–363.
Google Scholar - Godman GC, Miranda AF, Deitch AD, Tanenbaum SW. Action of cytochalasin D on cells of established lines. III. Zeiosis and movements at the cell surface. J Cell Biol 1975; 64: 644–667.
Google Scholar - Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445–1449.
Google Scholar - Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–1462.
Google Scholar - Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligands. Curr Op Immunol 1994; 6: 407–413.
Google Scholar - Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 1994; 76: 959–962.
Google Scholar - Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845–853.
Google Scholar - Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993; 268: 10932–10937.
Google Scholar - Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281: 1312–1316.
Google Scholar - Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 1998; 281: 1322–1326.
Google Scholar - Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673–682.
Google Scholar - Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687–12690.
Google Scholar - Sprick MR, Weigand MA, Rieser E, et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12: 599–609.
Google Scholar - Bodmer JL, Holler N, Reynard S, et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2000; 2: 241–243.
Google Scholar - Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, and Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12: 611–620
Google Scholar - Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol 1998; 143: 1353–1360.
Google Scholar - Vercammen D, Brouckaert G, Denecker G, et al. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998; 188: 919–930.
Google Scholar - Denecker G, Vercammen D, Steemans M, et al. Death receptor-induced apoptotic and necrotic cell death: Differential role of caspases and mitochondria. Cell Death Diff 2001; 8: 829–840.
Google Scholar - Kayagaki N, Yamaguchi N, Nakayama M, et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activatedNKcells. J Immunol 1999; 163: 1906–1913.
Google Scholar - Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Therapy 2000; 7: 1034–1038.
Google Scholar - Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Meth 1984; 68: 167–175.
Google Scholar - Martin SJ, Reutelingsperger CPM, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545–1556.
Google Scholar - Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD, Green DR. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 2001; 153: 319–328.
Google Scholar - Takeda K, Hayakawa Y, Smyth MJ, et al. Involvement of tumor necrosis factor-related apoptotis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001; 7: 94–100.
Google Scholar - Smyth MJ, Cretney E, Takeda K, et al. Tumor necrosis-factor-related apoptotis-inducing ligand (TRAIL) contributes to interferon _?_-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193: 661–670.
Google Scholar - Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997; 57: 3325–3330.
Google Scholar - Greenberg NM, DeMayo F, Finegold MJ, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92: 3439–3443.
Google Scholar - Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL. Adenoviral-mediated transfer of the TRAIL/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 2000; 165: 2886–2894.
Google Scholar - Griffith TS, Broghammer EL. Suppression of tumor growth following intralesional therapy with TRAIL/Apo-2L recombinant adenovirus. Mol Ther 2001; 4: 257–266.
Google Scholar - Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207–2216.
Google Scholar - Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029–4035.
Google Scholar - Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265: 17420–17423.
Google Scholar - Raynal P, Pollard HB. Annexins: The problem of assessing the biological role for a gene family of multifinctional clacium and phospholipid-binding proteins. Biochim Biophys Acta 1994; 1197: 63–93.
Google Scholar - Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415–1420.
Google Scholar - Muhlenbeck F, Haas E, Schwenzer R, et al. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem 1998; 273: 33091–33098.
Google Scholar - Muhlenbeck F, Schneider P, Bodmer J-L, et al. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. J Biol Chem 2000; 275: 32208–32213.
Google Scholar - Hu W-H, Johnson H, Shu H-B. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways. J Biol Chem 1999; 274: 30603–30610.
Google Scholar - Basu S, Kolesnick R. Stress signals for apoptosis: Ceramide and c-Jun kinase. Oncogene 1998; 17: 3277–3285.
Google Scholar - Tibbles LA, Woodgett JR. The stress-activated protein kinase pathways.Cell Mol Life Sci 1999; 55: 1230–1254.
Google Scholar - Gross A, Yin XM, Wang K, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/ Fas death. J Biol Chem 1999; 274: 1156–1163.
Google Scholar - Uchiyama Y. Apoptosis: The history and trends of its studies. Arch Histol Cytol 1995; 58: 127–137.
Google Scholar - Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999; 59: 2770–2775.
Google Scholar - Walczak H, Miller RE, Gliniak B, et al. Tumoricidal activity of TRAIL in vivo. Nat Med 1999; 5: 157–163.
Google Scholar - Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155–162.
Google Scholar - Gliniak B, Le T. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res 1999; 59: 6153–6158.
Google Scholar - Chinnaiyan AM, Prasad U, Shankar S, et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000; 97: 1754–1759.
Google Scholar - Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86–89.
Google Scholar - Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976; 143: 1283–1288.
Google Scholar - Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994; 264: 961–965.
Google Scholar - Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996; 184: 923–930.
Google Scholar - Albert ML, Pearce SFA, Francisco LM, et al. Immature dendritic cells phagocytose apoptotic cells via ?v?5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998; 188: 1359–1368.
Google Scholar - Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423–433.
Google Scholar - Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305–1308.
Google Scholar - Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489–495.
Google Scholar - Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998; 187: 1477–1485.
Google Scholar - Sane AT, Bertrand R. Caspase inhibition in camptothecintreated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Cancer Res 1999; 59: 3565–3569.
Google Scholar - Kim SO, Han J. Pan-caspase inhibitor zVAD enhances cell death in RAW246.7 macrophages. J Endotoxin Res 2001; 7: 292–296.
Google Scholar - Nakayama M, Ishidoh K, Kayagaki N, et al. Multiple Pathways of TWEAK-Induced Cell Death. J Immunol 2002; 168: 734–743.
Google Scholar - Dbaibo GS, Perry DK, Gamard CJ, et al. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 1997; 185: 481–490.
Google Scholar - Heller RA, Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994; 126: 5–9.
Google Scholar - Monney L, Olivier R, Otter I, Jansen B, Poirier GG, Borner C. Role of an acidic compartment in tumor-necrosis-factoralpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur J Biochem 1998; 251: 295–303.
Google Scholar - Erickson AH. Biosynthesis of lysosomal endopeptidases. J Cell Biochem 1989; 40: 31–41.
Google Scholar - Rowan AD, Mason P, Mach L, Mort JS. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J Biol Chem 1992; 267: 15993–15999.
Google Scholar - Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 19797; 272: 32401–32410.
Google Scholar - Solary E, Eymin B, Droin N, Haugg M. Proteases, proteolysis, and apoptosis. Cell Biol Toxicol 1998; 14: 121–132.
Google Scholar - Chan SL, Mattson MP. Caspase and calpain substrates: Roles in synaptic plasticity and cell death. J Neurosci Res 1999; 58: 167–190.
Google Scholar - Sarin A, Clerici M, Blatt SP, Hendrix CW, Shearer GM, Henkart PA. Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J Immunol 1994; 153: 862–872.
Google Scholar - Sarin A, Adams DH, Henkart PA. Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med 1993; 178: 1693–1700.
Google Scholar - Saito K, Elce JS, Hamos JE, Nixon RA.Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993; 90: 2628–2632.
Google Scholar